Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:40 PM
Ignite Modification Date:
2025-12-24 @ 3:40 PM
NCT ID:
NCT06174792
Eligibility Criteria:
Inclusion Criteria:
* age 18 years or older;
* regular menstrual cycle;
* adenomyosis diagnosed by imaging analysis (magnetic resonance imaging \[MRI\] or transvaginal ultrasound);
* no other treatment for adenomyosis for at least 3 months before drospirenone administration;
* painful symptoms (lower abdominal and/or lower back pain) with a score of three points or more on the verbal pain rating scale developed by Harada et al. during the menstrual cycle.
Exclusion Criteria:
* endometriosis or uterine leiomyoma diagnosed by imaging analysis (MRI or transvaginal ultrasound);
* benign ovarian cyst including endometrioma;
* other endocrine diseases;
* severe anemia (hemoglobin concentrations \<8.0 g/dL).
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT06174792
Study Brief:
Protocol Section:
NCT06174792